NCT06403488CompletedPhase 3
Letrozole Dose Increments in PCOS Patients Resistant to Letrozole
Letrozole Dose Increments in PCOS Patients Resistant to Letrozole Ovulation Induction
Source: ClinicalTrials.gov · Last updated 8 May 2024
Brief summary (registry, in English)
Objectives: To study the effect of Letrozole dose increments on ovulation rate and endometrial thickness as a primary outcomes in patients with polycystic ovary syndrome who previously resistant to letrazole conventional dose, and chemical and clinical pregnancy considered as secondary outcomes.
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 102 (actual)
- First submitted
- 3 May 2024
- Start date
- 1 Oct 2023
- Primary completion date
- 30 Jan 2024
- Lead sponsor
- Beni-Suef University
- NCT number
- NCT06403488
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 102
- From 1 Oct 2023 to the primary completion date, 30 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients received other medications for ovulation induction such as metformin or clomiphene citrate and gonadotropins concomitantly
Other
- Any contraindications for pregnancy
- hyperprolactinemia
- abnormal thyroid functions
- multiple uterine fibroids
Who the study is looking for
- normal semen analysis of their male partner
- Diagnosis of PCOS based on a modified form of the Rotterdam criteria
Age in the registry: 18 years to 40 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beni-Suef University Hospital Coordinator of this site? Confirm its status | Banī Suwayf | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.